Sign In
test

PAUL BRAUER JR

Silverarc Capital Management, Llc

Assets Managed
$979.812M
Holdings
73
Last Quarter
2026 - Q1
Filed Date
12d ago
Growth Rate
36.08%(2Q avg: 16.59%)
Sustained Growth
1 quarters

Portfolio positions

This chart displays the top 10 holdings in Silverarc Capital Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 73 positions.

Assets under management

The assets under management (AUM) of Silverarc Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 979.812M in assets, with a quarterly growth rate of 36.08% and a 2-quarter average growth rate of 16.59%. The portfolio is managed by PAUL BRAUER JR, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
ur-4⤦
Spdr S&p Biotech Etf
Recent Activity
New Position
10.76%
$105.377M↓ Put
825,000 shares@ $127.73 avg price
KALV
Kalvista Pharmaceuticals Inc
Recent Activity
Increased 18.52%
5.91%
$57.902M
2.876M shares@ $20.14 avg price
DNTH
Dianthus Therapeutics Inc
Recent Activity
Decreased -12.71%
5.61%
$54.946M
654,746 shares@ $83.92 avg price
COGT
Cogent Biosciences Inc
Recent Activity
Increased 5.54%
5.17%
$50.583M
1.314M shares@ $38.5 avg price
CELC
Celcuity Inc
Recent Activity
Decreased -4.59%
4.17%
$40.851M
357,903 shares@ $114.14 avg price
IMNM
Immunome Inc
Recent Activity
Increased 64.3%
4.13%
$40.466M
1.85M shares@ $21.88 avg price
KOD
Kodiak Sciences Inc
Recent Activity
Decreased -3.04%
3.86%
$37.812M
991,930 shares@ $38.13 avg price
NUVL
Nuvalent Inc-a
Recent Activity
Increased 13.97%
3.72%
$36.361M
354,914 shares@ $102.45 avg price
ABVX
Abivax Sa-adr
Recent Activity
Decreased -28.34%
3.44%
$33.687M
302,530 shares@ $111.36 avg price
GLUE
Monte Rosa Therapeutics Inc
Recent Activity
Increased 94.55%
3.37%
$32.934M
2.002M shares@ $16.45 avg price

1-10 of 73